Herbal drug Silymarin does not perturb hepatitis C virus, ALT levels Top Information

Herbal product silymarin (milk thistle) does not move the hepatitis C virus (HCV) or alanine aminotransferase (ALT) levels in the blood, say researchers.

The findings are based on a comparison between clinical data of silymarin owner and non-users, gathered wound up a examine of patients with chronic hepatitis C.

All patients in the survey were those who had participated in a National Institute of Diabetes and Digestive and Kidney Diseases-sponsored long-term treatment test for patients who had failed to respond previously to antiviral therapy.

The researchers asked participants about their past and current apply of all prescription and non-prescription drugs, including herbal medications, dietary supplements and other botanical products. Of 1145 study participants, 56 percent said that they had never used herbal products, while 23 percent were using them currently, some 60 different varieties. Silymarin was by far the most common.

Upon comparing the clinical information of silymarin users and non-users, the researchers found that "the levels of HCV RNA were not significantly contradistinctive between silymarin users and non-users," indicating no chain reaction on virus activity. The product did not still alter serum ALT levels, indicating no effect on hepatic inflammation.

The authors further observed that silymarin purchaser reported less fatigue, nausea, liver pain, anorexia, muscle and joint pain and better general form than non-users.

However, they insist that the exceeding scores in a small number of symptoms among silymarin users compared to non-users are insufficient to help the value of this alternative therapy.

According to them, compelling information can approach only if a scientifically valid glance at is performed.

Currently in progress, therefore, is a properly designed prospective, randomized, controlled trial in which a fully characterized, purified and standardized silymarin formulation is being evaluated," they report. The study has been published in Hepatology, a journal published near Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).

Technical View on Stocks Subscribe to Print Issue January Editions. 19) Three accused found answerable in Kandahar hijacking case (19) January Print Edition Preview : Now) Board Meeting of Patni Computer Systems Ltd. Now) Rollatainers Ltd. Announces Board Meeting (Now) Zodiac Jrd Mkj Ltd. Declares Board Meeting (Now) Board Meeting of Twentyfirst Century Management Services Ltd.

Now) added Active forum topics Sunita Williams became a Muslim ? Recent comments Hazy Furture Ahead for Pakistan.. 3 weeks 2 days ago Straph infection..

From http://topnews.in/herbal-drug-silymarin-does-not-affect-hepa~